Absci (ABSI) Total Debt (2020 - 2026)
Absci (ABSI) posted Total Debt of $12.8 million for Q3 2025, down 0.74% sequentially from $12.9 million in Q2 2025, and up 494.66% YoY from $2.2 million in Q3 2024.
Analysis
Absci (ABSI) Total Debt (2020 - 2026) Analysis & Trends
Absci has reported Total Debt for 6 years, with the latest figure at $12.8 million in Q3 2025.
- Quarterly Total Debt rose 494.66% year-over-year to $12.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $12.8 million (up 494.66% YoY) and the FY2024 annual result came in at $14.0 million, down 19.55% from the prior year.
- Total Debt fell to $12.8 million in Q3 2025 per ABSI's latest filing, from $12.9 million in the prior quarter.
- Over five years, Total Debt peaked at $17.4 million in Q4 2023 and troughed at $531000.0 in Q1 2022.
- A 5-year average of $7.1 million and a median of $6.4 million in 2022 frame the typical range for Total Debt.
- The sharpest annual moves came in 2021 and 2023: Total Debt slumped 76.45% in 2021, then soared 1254.05% in 2023.
- Over 5 years, Total Debt stood at $1.1 million in 2021, then surged by 610.32% to $8.0 million in 2022, then surged by 118.06% to $17.4 million in 2023, then fell by 19.55% to $14.0 million in 2024, then decreased by 8.51% to $12.8 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $12.8 million, $12.9 million, and $13.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1.07 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 9.34 Bn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | 150,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 150,000.00 |
| Mar 31, 2026 | 413,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 14.12 Mn |
| Jun 30, 2025 | 14.90 Mn |
| Mar 31, 2025 | 15.98 Mn |
| Dec 31, 2024 | 16.74 Mn |
| Sep 30, 2024 | 5.43 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 7.05 Mn |
| Dec 31, 2023 | 20.67 Mn |
| Sep 30, 2023 | 8.76 Mn |
| Jun 30, 2023 | 9.52 Mn |
| Mar 31, 2023 | 10.27 Mn |
| Dec 31, 2022 | 10.93 Mn |
| Sep 30, 2022 | 8.87 Mn |
| Jun 30, 2022 | 9.26 Mn |
| Mar 31, 2022 | 2.93 Mn |
| Dec 31, 2021 | 3.52 Mn |
| Sep 30, 2021 | 4.11 Mn |